Cargando…
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
Allergic diseases are among the most common health issues worldwide. Specific immunotherapy has remained the only disease-modifying treatment, but it is not effective in all patients and may cause side effects. Over the last 25 years, allergen molecules from most prevalent allergen sources have been...
Autores principales: | Marth, Katharina, Focke-Tejkl, Margarete, Lupinek, Christian, Valenta, Rudolf, Niederberger, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025905/ https://www.ncbi.nlm.nih.gov/pubmed/24860720 http://dx.doi.org/10.1007/s40521-013-0006-5 |
Ejemplares similares
-
Monitoring Allergen Immunotherapy Effects by Microarray
por: Lupinek, Christian, et al.
Publicado: (2016) -
Is The Allergen Really Needed in Allergy Immunotherapy?
por: Kündig, Thomas M., et al.
Publicado: (2014) -
Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018) -
Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy
por: Kouser, Lubna, et al.
Publicado: (2017) -
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)